TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity


TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2020Renaissance Technologies LLCBuy892,4314,091,463$50,448
Q2 2020Miller Value PartnersSell-67,8907,850,472$96,796
Q2 2020ARK InvestBuy43,86999,992$1,233
Q1 2020Sequoia Financial AdvisorsBuy14,02514,025$126
Q1 2020Renaissance Technologies LLCBuy967,0363,199,032$28,727
Q1 2020Miller Value PartnersSell-1,915,7057,918,362$71,107
Q1 2020Berkshire HathawaySell-460,00042,789,295$384,248
Q1 2020ARK InvestBuy9,99456,123$504
Q4 2019Renaissance Technologies LLCSell-4,706,6672,231,996$21,874
Q4 2019Miller Value PartnersBuy1,342,9159,834,067$96,374
Q4 2019ARK InvestSell-10,56946,129$452
Q3 2019Renaissance Technologies LLCSell-2,847,4006,938,663$47,738
Q3 2019Miller Value PartnersBuy1,990,9008,491,152$58,419
Q3 2019Abrams Capital ManagementBuy6,000,00024,046,356$165,439
Q3 2019ARK InvestBuy22,29156,698$390
Q2 2019Miller Value PartnersBuy1,957,7206,500,252$59,997
Q2 2019Renaissance Technologies LLCBuy7,159,9009,786,063$90,325
Q2 2019ARK InvestBuy9,94534,407$318
Q1 2019Renaissance Technologies LLCSell-4,315,8222,626,163$41,178
Q1 2019Miller Value PartnersBuy630,7304,542,532$71,227
Q1 2019Abrams Capital ManagementSell-476,01618,046,356$282,967
Q1 2019ARK InvestBuy85624,462$384
Q4 2018Miller Value PartnersBuy6,3503,911,802$60,320
Q4 2018Renaissance Technologies LLCBuy3,472,3226,941,985$107,045
Q4 2018Abrams Capital ManagementSell-1,000,00018,522,372$285,615
Q4 2018ARK InvestBuy54323,606$364
Q3 2018Renaissance Technologies LLCBuy2,568,7003,469,663$74,737
Q3 2018Miller Value PartnersBuy1,316,8403,905,452$84,123
Q3 2018Abrams Capital ManagementSell-220,75119,522,372$420,512
Q3 2018ARK InvestSell-7,42423,063$497

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.